On the recordJuly 11, 2017
It is past time for Congress to act, and as FDA's authorizing committee it is our job to clarify the statute.
Source
congress.govEditor's note · Context
Walden emphasizes the need for Congress to clarify FDA regulations on off-label drug communications.
Share
More from Greg Walden
Nov 17, 2020
I don't believe we have any other Members wishing to speak on this legislation, so I will just close and say it is another great work product from our Energy and Commerce Committee, bipartisan legislation that I encourage our colleagues to…
Oct 1, 2020
I thank my colleagues for bringing this legislation forward, and especially Chairman Grijalva and Ranking Member Bishop. I also thank Oregon senators, Merkley and Wyden, for their efforts on this, too. Irrigators in the Klamath Basin…
Nov 17, 2020
I don't believe I have any other speakers on our side of the aisle on this legislation, so I would urge its passage. Madam Speaker, I yield back the balance of my time.
Sep 29, 2020
I want to thank my colleagues, especially my friend from New Mexico for his leadership on this legislation. I would just say that they have all worked very hard on this. It is extraordinarily important to pass this. Madam Speaker, I yield…
Other voices in this conversation
